Skip to content

Transcutaneous auricular vagus nerve stimulation on postoperative sleep quality in sevoflurane-anesthetized patients: a double-blind randomized controlled trial

Effect of Transcutaneous Auricular Vagus Nerve Electrical Stimulation on Sleep Quality After General Anesthesia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500107698
Enrollment
Unknown
Registered
2025-08-18
Start date
2025-08-22
Completion date
Unknown
Last updated
2025-08-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sleep disturbances

Interventions

tVNS group:Intraoperative transcutaneous electrical stimulation of the vagus nerve was performed.
Control group:Sham stimulation

Sponsors

The First Hospital Of Jiaxing
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Age 18~65 years old. 2. ASA level I-III; 3. Receive general anesthesia maintained only by sevoflurane and remifentanil. 4. Elective surgery with an expected operation time of 1-4 hours. 5. Preoperative PSQI score <=5 points (normal sleep quality). 6. Abdominal surgery or orthopedic surgery; 7. Signed informed consent form;

Exclusion criteria

Exclusion criteria: 1. Vagus neuropathy (diabetic autonomic neuropathy, history of vagus nerve sect); 2. Central nervous system diseases (such as epilepsy, sequelae of stroke, Parkinson's disease); 3. Sleep-related movement disorders (such as restless legs syndrome, periodic limb movement disorder); 4. Suffering from uncontrolled major mental disorders (such as major depression, bipolar disorder, schizophrenia); 5. Patients with suspected or suffering from sleep apnea syndrome. 6. Severe arrhythmias (such as atrial fibrillation, sinus brady=8); 9. Those who use sedatives, hypnotics or sleep-promoting drugs (including but not limited to benzodiazepines, zolpidem, melatonin and their receptor agonists) within one month before surgery. 10. Patients who have undergone surgery in the past month. 11. Emergency surgery; 12. Anatomical deformity of the ear (concha defect); 13. Chronic otitis media/ear skin breakage; 14. Those with cognitive dysfunction (Mini-Mental State Examination MMSE <24 points), or clinically diagnosed with mild cognitive impairment (MCI)/dementia; 15. Those who have been diagnosed with delirium by the Confusion Assessment Method (CAM). 16. Pregnancy/lactation; 17. Those who cannot complete the research evaluation due to < 6 years of formal education.

Design outcomes

Primary

MeasureTime frame
Pittsburgh Sleep Quality Index;Richards-Campbell Sleep Questionnaire,RCSQ;

Secondary

MeasureTime frame
The Quality of Recovery-15 (QoR-15) score at 24 hours postoperatively.;Types and measurement of analgesic drugs;Numeric Rating Scale, NRS;Anxiety and depression scores;Delirium, adverse reactions, nausea and vomiting, etc;Epworth Sleepiness Scale;

Countries

China

Contacts

Public ContactTong Wu

The First Hospital of Jiaxing, Affiliated Hospital of JiaXing University

wutong129@163.com+86 151 6737 3439

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026